MedTrace Logo

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

NCT01011738 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1842

Last updated 2017-04-10

Study results available
· View outcomes & findings →

Summary

This observational, non-interventional cohort study will evaluate predictors of response in patients with chronic hepatitis B receiving standard of care Pegasys therapy. Efficacy and safety parameters will also be evaluated. Patients included in the study will be followed for the duration of their treatment and for up to 3 years thereafter.

Conditions

  • Hepatitis B, Chronic

Sponsors & Collaborators

Principal Investigators

  • Clinical Trials · Hoffmann-La Roche

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-11
Primary Completion
2014-11-18
Completion
2014-11-18

Countries

  • Austria
  • Bahrain
  • Bangladesh
  • Bosnia and Herzegovina
  • Bulgaria
  • China
  • Egypt
  • France
  • Germany
  • Hong Kong
  • India
  • Indonesia
  • Ireland
  • Jordan
  • Lebanon
  • Morocco
  • New Zealand
  • North Macedonia
  • Pakistan
  • Poland
  • Portugal
  • Romania
  • Saudi Arabia
  • South Korea
  • Thailand
  • United Arab Emirates
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01011738 on ClinicalTrials.gov